|
US3159547A
(en)
*
|
1963-06-28 |
1964-12-01 |
Abbott Lab |
Method of lowering blood pressure with 4-(2-amino-4-pyrimidylamino)-benzene-sulfonamide
|
|
US3320256A
(en)
|
1965-04-09 |
1967-05-16 |
Hoffmann La Roche |
Fluorinated imidazoo[1, 2-c]pyrimidines and pyrimido[1, 2-c]pyrimidines
|
|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
JPS5845466A
(ja)
|
1981-09-10 |
1983-03-16 |
松下電器産業株式会社 |
空気調和機
|
|
GR80171B
(en)
|
1983-08-29 |
1985-01-02 |
Ciba Geigy Ag |
N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
|
|
HU192875B
(en)
|
1984-10-05 |
1987-07-28 |
Richter Gedeon Vegyeszet |
Process for preparing 2-pyridinethiol derivatives
|
|
JPH07100685B2
(ja)
*
|
1985-08-02 |
1995-11-01 |
レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） |
新規ビタミンｄ類似体
|
|
DE3618353A1
(de)
|
1986-05-31 |
1987-12-03 |
Hoechst Ag |
Schaedlingsbekaempfungsmittel auf der basis von aminopyrimidin-derivaten sowie neue aminopyrimidin-verbindungen
|
|
EP0285571B1
(de)
|
1987-04-02 |
1992-02-05 |
Ciba-Geigy Ag |
Reaktivfarbstoffe, deren Herstellung und Verwendung
|
|
SU1499883A1
(ru)
|
1987-11-24 |
1991-10-23 |
Научно-исследовательский институт фармакологии АМН СССР |
Дихлоргидрат 2,4-бис-(п-трет-бутиланилино)-5-окси-6-метилпиримидина, обладающий анальгетической и противовоспалительной активностью
|
|
KR0144358B1
(ko)
*
|
1988-04-21 |
1998-07-15 |
피. 라이달 크리스텐슨 |
비타민 d 동족체
|
|
HU206337B
(en)
*
|
1988-12-29 |
1992-10-28 |
Mitsui Petrochemical Ind |
Process for producing pyrimidine derivatives and pharmaceutical compositions
|
|
US4969781A
(en)
*
|
1989-04-07 |
1990-11-13 |
The B. F. Goodrich Company |
Blind fastener hand tool
|
|
IE63502B1
(en)
*
|
1989-04-21 |
1995-05-03 |
Zeneca Ltd |
Aminopyrimidine derivatives useful for treating cardiovascular disorders
|
|
US4983608A
(en)
*
|
1989-09-05 |
1991-01-08 |
Hoechst-Roussell Pharmaceuticals, Inc. |
N-substituted-4-pyrimidinamines and pyrimidinediamines
|
|
US5179204A
(en)
|
1989-09-05 |
1993-01-12 |
Hoechst-Roussel Pharmaceuticals Incorporated |
N-substituted-4-pyrimidinamines and pyrimidinediamines
|
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
Ｎ―（１ｈ―テトラゾール―５―イル）―２―アニリノ―５―ピリミジンカルボキシアミド類及びその合成中間体
|
|
TW224941B
(https=)
|
1989-11-08 |
1994-06-11 |
Yamanouchi Pharma Co Ltd |
|
|
US5532228A
(en)
*
|
1990-02-06 |
1996-07-02 |
Schering Aktiengesellschaft |
Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
|
|
DE4011682A1
(de)
*
|
1990-04-06 |
1991-10-10 |
Schering Ag |
24-oxa-derivate in der vitamin d-reihe
|
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
|
DE4029650A1
(de)
|
1990-09-19 |
1992-03-26 |
Hoechst Ag |
2-anilino-pyrimidine, verfahren zu ihrer herstellung, sie enthaltene mittel und ihre verwendung als fungizide
|
|
JPH04178385A
(ja)
|
1990-11-09 |
1992-06-25 |
Yamanouchi Pharmaceut Co Ltd |
ジケトピリドピラジン誘導体
|
|
US5246948A
(en)
*
|
1991-05-10 |
1993-09-21 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, their production and use
|
|
US5200400A
(en)
*
|
1991-07-12 |
1993-04-06 |
New England Deaconess Hospital Corporation |
Method for inhibiting allograft rejection using photoactivatable nucleotides or nucleosides
|
|
CA2074864A1
(en)
|
1991-07-30 |
1993-01-31 |
Carmen Almansa |
Tetralones with pharmacological activity
|
|
US5728536A
(en)
|
1993-07-29 |
1998-03-17 |
St. Jude Children's Research Hospital |
Jak kinases and regulation of Cytokine signal transduction
|
|
DE4141746A1
(de)
*
|
1991-12-13 |
1993-06-17 |
Schering Ag |
20-methyl-substituierte vitamin d-derivate
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5194431A
(en)
*
|
1992-07-08 |
1993-03-16 |
Wisconsin Alumni Research Foundation |
24-cyclopropane vitamin D derivatives
|
|
TW287160B
(https=)
*
|
1992-12-10 |
1996-10-01 |
Hoffmann La Roche |
|
|
BR9407799A
(pt)
|
1993-10-12 |
1997-05-06 |
Du Pont Merck Pharma |
Composição de matéria método de tratamento e composição farmaceutica
|
|
IL112290A
(en)
|
1994-01-12 |
1999-01-26 |
Novartis Ag |
Transformed aryl and the troiryl pyrimidines and herbicides containing them
|
|
CA2150609C
(en)
|
1994-06-01 |
1998-12-08 |
Mikiro Yanaka |
Pyrimidine derivatives and pharmaceutical composition
|
|
US5733932A
(en)
*
|
1995-01-06 |
1998-03-31 |
The Picower Institute For Medical Research |
Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
|
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US5700904A
(en)
|
1995-06-07 |
1997-12-23 |
Eli Lilly And Company |
Preparation of an acylated protein powder
|
|
US6316635B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
GB9516121D0
(en)
|
1995-08-05 |
1995-10-04 |
Pfizer Ltd |
Organometallic addition to ketones
|
|
WO1997008147A1
(de)
|
1995-08-24 |
1997-03-06 |
Basf Aktiengesellschaft |
N-heterocyclische verbindungen, zwischenprodukte für ihre herstellung, sie enthaltende mittel und ihre verwendung zur bekämpfung von schadpilzen
|
|
GB9523675D0
(en)
*
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP4058129B2
(ja)
*
|
1996-03-18 |
2008-03-05 |
株式会社資生堂 |
ピリジン誘導体及び抗潰瘍剤、抗菌剤
|
|
TW440563B
(en)
*
|
1996-05-23 |
2001-06-16 |
Hoffmann La Roche |
Aryl pyrimidine derivatives and a pharmaceutical composition thereof
|
|
US6696448B2
(en)
*
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
GB9619284D0
(en)
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6004985A
(en)
*
|
1996-10-09 |
1999-12-21 |
Berlex Laboratories, Inc. |
Thio acid derived monocylic N-heterocyclics as anticoagulants
|
|
WO1998033798A2
(en)
|
1997-02-05 |
1998-08-06 |
Warner Lambert Company |
Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
|
|
GB9705361D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6486185B1
(en)
*
|
1997-05-07 |
2002-11-26 |
Sugen, Inc. |
3-heteroarylidene-2-indolinone protein kinase inhibitors
|
|
US6316429B1
(en)
*
|
1997-05-07 |
2001-11-13 |
Sugen, Inc. |
Bicyclic protein kinase inhibitors
|
|
US6987113B2
(en)
*
|
1997-06-11 |
2006-01-17 |
Sugen, Inc. |
Tyrosine kinase inhibitors
|
|
SE9702401D0
(sv)
*
|
1997-06-19 |
1997-06-19 |
Astra Ab |
Pharmaceutical use
|
|
GB9718913D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
|
US6133305A
(en)
*
|
1997-09-26 |
2000-10-17 |
Sugen, Inc. |
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
|
|
US6093820A
(en)
*
|
1997-10-02 |
2000-07-25 |
Taro Pharmaceutical Industries Ltd. |
Method and reagents for N-alkylating ureides
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
GB9723859D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Compound,composition and use
|
|
DE19750701A1
(de)
|
1997-11-15 |
1999-05-20 |
Dystar Textilfarben Gmbh & Co |
Verfahren zur Umsetzung von fluorsubstituierten Heterocyclen mit Aminen in Gegenwart von Phasentransfer-Katalysatoren
|
|
EP1054004B1
(en)
|
1997-12-15 |
2008-07-16 |
Astellas Pharma Inc. |
Novel pyrimidine-5-carboxamide derivatives
|
|
AU754965B2
(en)
|
1997-12-31 |
2002-11-28 |
University Of Kansas, The |
Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
|
|
JP2002503655A
(ja)
*
|
1998-02-13 |
2002-02-05 |
ファルマシア・アンド・アップジョン・カンパニー |
抗菌剤として有用な置換アミノフェニルイソオキサゾリン誘導体
|
|
EA200000840A1
(ru)
|
1998-02-17 |
2001-02-26 |
Туларик, Инк. |
Антивирусные производные пиримидина
|
|
JP2002506873A
(ja)
|
1998-03-18 |
2002-03-05 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
複素環式シグナル伝達阻害剤、それを含む組成物
|
|
KR100643419B1
(ko)
|
1998-03-27 |
2006-11-10 |
얀센 파마슈티카 엔.브이. |
Ｈｉｖ를 억제하는 피리미딘 유도체
|
|
EA002973B1
(ru)
|
1998-03-27 |
2002-12-26 |
Янссен Фармацевтика Н.В. |
Производные пиримидина в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
GB9806739D0
(en)
|
1998-03-28 |
1998-05-27 |
Univ Newcastle Ventures Ltd |
Cyclin dependent kinase inhibitors
|
|
JP2003504301A
(ja)
|
1998-04-01 |
2003-02-04 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
インテグリンアンタゴニスト
|
|
US6531279B1
(en)
*
|
1998-04-15 |
2003-03-11 |
Genset S.A. |
Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
|
|
JP2002516322A
(ja)
|
1998-05-22 |
2002-06-04 |
スミスクライン・ビーチャム・コーポレイション |
新規２−アルキル置換イミダゾール化合物
|
|
WO2000000202A1
(en)
|
1998-06-30 |
2000-01-06 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using jak-3 inhibitors
|
|
KR20010089171A
(ko)
|
1998-08-21 |
2001-09-29 |
추후제출 |
퀴나졸린 유도체
|
|
ATE342892T1
(de)
|
1998-08-29 |
2006-11-15 |
Astrazeneca Ab |
Pyrimidine verbindungen
|
|
DE19851421A1
(de)
|
1998-11-07 |
2000-05-11 |
Boehringer Ingelheim Pharma |
Neue Pyrimidine, deren Herstellung und Verwendung
|
|
SK287270B6
(sk)
|
1998-11-10 |
2010-05-07 |
Janssen Pharmaceutica N. V. |
Derivát pyrimidínu
|
|
WO2000027802A1
(en)
|
1998-11-12 |
2000-05-18 |
Ariad Pharmaceuticals, Inc. |
Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
|
|
US6127376A
(en)
|
1998-12-04 |
2000-10-03 |
Berlex Laboratories, Inc. |
Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
|
|
GB9828511D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
US6841567B1
(en)
*
|
1999-02-12 |
2005-01-11 |
Cephalon, Inc. |
Cyclic substituted fused pyrrolocarbazoles and isoindolones
|
|
US6673908B1
(en)
*
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
|
US6624171B1
(en)
*
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
SE9901079D0
(sv)
|
1999-03-23 |
1999-03-23 |
Astra Ab |
Novel compounds
|
|
BR0009338A
(pt)
|
1999-03-26 |
2001-12-26 |
Astrazeneca Ab |
Composto, processo para a preparação do mesmo,composição farmacêutica, processo para apreparação da mesma, uso de um composto, e,método de tratamento de uma doençainflamatória em um paciente sofrendo ou em riscode dita doença
|
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
|
AU4198400A
(en)
|
1999-04-06 |
2000-10-23 |
Krenitsky Pharmaceuticals Inc. |
Neurotrophic thio substituted pyrimidines
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
DE19917785A1
(de)
|
1999-04-20 |
2000-10-26 |
Bayer Ag |
2,4-Diamino-pyrimidin-Derivate
|
|
WO2000076980A1
(en)
|
1999-06-10 |
2000-12-21 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
WO2001000213A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
US7169778B2
(en)
|
1999-09-15 |
2007-01-30 |
Warner-Lambert Company |
Pteridinones as kinase inhibitors
|
|
TR200200763T2
(tr)
|
1999-09-24 |
2003-09-22 |
Janssen Pharmaceutica N.V. |
Antiviral bileşimler
|
|
DE19945982A1
(de)
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
KR100317935B1
(ko)
|
1999-10-20 |
2001-12-22 |
유승필 |
대사성 골질환 치료용 약제조성물 및 이의 제조방법
|
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
WO2001030782A2
(en)
|
1999-10-29 |
2001-05-03 |
Syngenta Participations Ag |
Novel herbicides
|
|
CA2392554A1
(en)
|
1999-11-30 |
2001-06-28 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
DE60037345T2
(de)
|
1999-12-10 |
2008-11-13 |
Pfizer Products Inc., Groton |
Pyrrolo(2,3-d)pyrimidin-Verbindungen
|
|
CO5271715A1
(es)
*
|
1999-12-21 |
2003-04-30 |
Sugen Inc |
7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa
|
|
EP1246823A1
(en)
|
1999-12-28 |
2002-10-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
US6362172B2
(en)
|
2000-01-20 |
2002-03-26 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
|
EP1250137B1
(en)
|
2000-01-24 |
2007-08-15 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
|
|
KR20010111298A
(ko)
*
|
2000-02-05 |
2001-12-17 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｅｒｋ의 억제제로서 유용한 피라졸 조성물
|
|
JP4739632B2
(ja)
*
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｅｒｋのインヒビターとして有用なピラゾール組成物
|
|
AU3704101A
(en)
|
2000-02-17 |
2001-08-27 |
Amgen Inc |
Kinase inhibitors
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004886D0
(en)
*
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6525051B2
(en)
*
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
US6608048B2
(en)
*
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
AU783981C
(en)
|
2000-05-08 |
2007-05-03 |
Janssen Pharmaceutica N.V. |
HIV replication inhibitors
|
|
AU782948B2
(en)
|
2000-05-08 |
2005-09-15 |
Janssen Pharmaceutica N.V. |
Prodrugs of HIV replication inhibiting pyrimidines
|
|
ATE423120T1
(de)
|
2000-06-26 |
2009-03-15 |
Pfizer Prod Inc |
Pyrroloä2,3-düpyrimidin verbindungen als immunosuppressive wirkstoffe
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
|
DE60118576T2
(de)
|
2000-08-18 |
2006-11-02 |
3M Innovative Properties Co., Saint Paul |
Fluoro(meth)acrylatecopolymer-beschichtungsmassen
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002028862A2
(en)
*
|
2000-10-02 |
2002-04-11 |
Emory University |
Triptolide analogs for the treatment of autoimmune and inflammatory disorders
|
|
US6448401B1
(en)
*
|
2000-11-20 |
2002-09-10 |
Bristol-Myers Squibb Company |
Process for water soluble azole compounds
|
|
AU2001229722A1
(en)
|
2000-11-29 |
2002-06-11 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
US20020115173A1
(en)
*
|
2000-12-11 |
2002-08-22 |
Children's Medical Center Corporation |
Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
|
|
EP1351691A4
(en)
|
2000-12-12 |
2005-06-22 |
Cytovia Inc |
SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF
|
|
WO2002055517A2
(en)
*
|
2000-12-20 |
2002-07-18 |
Jingrong Cui |
4-(hetero)aryl substituted indolinones
|
|
BR0116452A
(pt)
*
|
2000-12-21 |
2003-09-30 |
Glaxo Group Ltd |
Composto, composição farmacêutica, uso de um composto
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US20040102455A1
(en)
*
|
2001-01-30 |
2004-05-27 |
Burns Christopher John |
Method of inhibiting kinases
|
|
AUPR279101A0
(en)
*
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
ES2316546T3
(es)
|
2001-02-20 |
2009-04-16 |
Astrazeneca Ab |
2-arilamino-pirimidinas para el tratamiento de trastornos asociados a gsk3.
|
|
PL364625A1
(en)
|
2001-02-23 |
2004-12-13 |
Merck & Co, Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
GB2373186A
(en)
|
2001-02-23 |
2002-09-18 |
Astrazeneca Ab |
Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
|
|
ATE497603T1
(de)
|
2001-03-02 |
2011-02-15 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
BR0209774A
(pt)
|
2001-05-29 |
2004-06-01 |
Schering Ag |
Pirimidinas inibidoras de cdk, sua preparação e aplicação como medicamento
|
|
MXPA03010961A
(es)
*
|
2001-05-31 |
2004-02-27 |
Vertex Pharma |
Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
|
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
ES2274035T3
(es)
|
2001-06-01 |
2007-05-16 |
Vertex Pharmaceuticals Incorporated |
Compuestos de tiazol utiles como inhibidores de proteina quinasas.
|
|
CA2450769A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
AU2002315388A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel phenylamino-pyrimidines and uses thereof
|
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
AP2003002929A0
(en)
*
|
2001-06-23 |
2003-12-31 |
Aventis Pharma Inc |
Pyrrolopyrimidines as protein kinase inhibitors
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
|
US7115617B2
(en)
*
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
US6939874B2
(en)
*
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
US6433018B1
(en)
*
|
2001-08-31 |
2002-08-13 |
The Research Foundation Of State University Of New York |
Method for reducing hypertrophy and ischemia
|
|
US7070996B2
(en)
*
|
2001-08-31 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
|
|
WO2003020698A2
(en)
|
2001-09-06 |
2003-03-13 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
US6777417B2
(en)
*
|
2001-09-10 |
2004-08-17 |
Sugen, Inc. |
3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
|
|
WO2003030909A1
(en)
*
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
WO2003026664A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Corporation |
2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
|
WO2003040141A1
(en)
*
|
2001-09-28 |
2003-05-15 |
Bayer Pharmaceuticals Corporation |
Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
ATE407678T1
(de)
|
2001-10-17 |
2008-09-15 |
Boehringer Ingelheim Pharma |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
|
US6897208B2
(en)
*
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
KR101031720B1
(ko)
|
2001-11-28 |
2011-04-29 |
비티지 인터내셔널 리미티드 |
질소함유 헤테로아릴 화합물을 함유하는 알츠하이머병의예방약 또는 치료약 또는 아밀로이드 단백질 섬유화억제제
|
|
PY0228255A
(es)
|
2001-12-06 |
2004-06-01 |
Pfizer Prod Inc |
Compuestos cristalinos novedosos
|
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
WO2003055489A1
(en)
|
2001-12-21 |
2003-07-10 |
Bayer Pharmaceuticals Corporation |
2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
US20030158195A1
(en)
*
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
EP1470121B1
(en)
|
2002-01-23 |
2012-07-11 |
Bayer HealthCare LLC |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US6998391B2
(en)
*
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
AU2003209077A1
(en)
|
2002-02-08 |
2003-09-02 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
AU2003220970A1
(en)
|
2002-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
US7288547B2
(en)
|
2002-03-11 |
2007-10-30 |
Schering Ag |
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
|
|
EP1483260A1
(de)
|
2002-03-11 |
2004-12-08 |
Schering Aktiengesellschaft |
Cdk inhibitorische 2-heteroaryl-pyrimidine, deren herstellung und verwendung als arzneimittel
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
GEP20074230B
(en)
|
2002-03-20 |
2007-11-12 |
Bristol Myers Squibb Co |
Phosphate prodrugs of fluorooxindoles
|
|
AU2003301758A1
(en)
|
2002-05-06 |
2004-05-25 |
Bayer Pharmaceuticals Corporation |
Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
|
|
WO2003095448A1
(en)
|
2002-05-06 |
2003-11-20 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
AR039540A1
(es)
|
2002-05-13 |
2005-02-23 |
Tibotec Pharm Ltd |
Compuestos microbicidas con contenido de pirimidina o triazina
|
|
JP2005528443A
(ja)
*
|
2002-05-30 |
2005-09-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター
|
|
CA2489458A1
(en)
|
2002-06-14 |
2003-12-24 |
Altana Pharma Ag |
Substituted diaminopyrimidines
|
|
CA2489648A1
(en)
|
2002-06-17 |
2003-12-24 |
Smithkline Beecham Corporation |
Chemical process
|
|
EP1518855B1
(en)
|
2002-06-28 |
2011-10-26 |
Astellas Pharma Inc. |
Diaminopyrimidinecarboxa mide derivative
|
|
US6758434B2
(en)
*
|
2002-07-03 |
2004-07-06 |
Kimberly-Clark Worldwide, Inc. |
Dispenser for multiple rolls of sheet material
|
|
WO2004009957A1
(en)
|
2002-07-23 |
2004-01-29 |
Halliburton Energy Services, Inc. |
Subterranean well pressure and temperature measurement
|
|
HRP20050089B1
(hr)
*
|
2002-07-29 |
2015-06-19 |
Rigel Pharmaceuticals |
Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
|
|
AU2003249539A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
DE10243291B4
(de)
*
|
2002-09-18 |
2015-04-30 |
Mann + Hummel Gmbh |
Ventil, insbesondere für den Ölkreislauf einer Brennkraftmaschine
|
|
AU2003286876A1
(en)
|
2002-11-01 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
US7259161B2
(en)
|
2002-11-04 |
2007-08-21 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
EP1560824A1
(en)
|
2002-11-05 |
2005-08-10 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
|
GB0226582D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Anti-viral compounds
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
|
AU2003278529A1
(en)
|
2002-11-21 |
2004-06-15 |
Pfizer Products Inc. |
3-amino-piperidine derivatives and processes for their preparation
|
|
NZ539901A
(en)
|
2002-11-26 |
2007-09-28 |
Pfizer Prod Inc |
Method of treatment of transplant rejection
|
|
JP2006508997A
(ja)
|
2002-11-28 |
2006-03-16 |
シエーリング アクチエンゲゼルシャフト |
Ｃｈｋ−、Ｐｄｋ−およびＡｋｔ−阻害性ピリミジン、それらの製造および薬剤としての使用
|
|
WO2004050068A1
(en)
|
2002-11-29 |
2004-06-17 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
CA2506432A1
(en)
|
2002-12-09 |
2004-06-24 |
Robert A. Kirken |
Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
|
|
JPWO2004054617A1
(ja)
|
2002-12-13 |
2006-04-20 |
協和醗酵工業株式会社 |
中枢疾患の予防および／または治療剤
|
|
DE60326646D1
(de)
|
2002-12-18 |
2009-04-23 |
Vertex Pharma |
Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen
|
|
US7098332B2
(en)
*
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
US20040242613A1
(en)
|
2003-01-30 |
2004-12-02 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of PKC-theta
|
|
BRPI0407329A
(pt)
|
2003-02-07 |
2006-01-10 |
Janssen Pharmaceutica Nv |
Derivados de pirimidina para a prevenção de infecção de hiv
|
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
|
CL2004000306A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
AU2004230841A1
(en)
*
|
2003-04-03 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
MXPA05011523A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas.
|
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1651595A2
(en)
|
2003-05-30 |
2006-05-03 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
WO2005007646A1
(en)
|
2003-07-10 |
2005-01-27 |
Neurogen Corporation |
Substituted heterocyclic diarylamine analogues
|
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
AU2004260738B2
(en)
|
2003-07-16 |
2009-07-16 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
WO2005009980A1
(en)
|
2003-07-22 |
2005-02-03 |
Neurogen Corporation |
Substituted pyridin-2-ylamine analogues
|
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
US7504429B2
(en)
|
2003-07-24 |
2009-03-17 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2005012294A1
(en)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
EP1648875A1
(en)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
WO2005013982A1
(en)
|
2003-08-06 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
EA200600225A1
(ru)
|
2003-08-14 |
2006-08-25 |
Пфайзер Инк. |
Производные пиперазина для лечения вич инфекций
|
|
PT1660458E
(pt)
|
2003-08-15 |
2012-04-27 |
Novartis Ag |
2,4-pirimidinodiaminas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
WO2005028467A1
(en)
|
2003-09-15 |
2005-03-31 |
Anadys Pharmaceuticals, Inc. |
Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
US20070105839A1
(en)
|
2003-09-18 |
2007-05-10 |
Patricia Imbach |
2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
WO2005027848A2
(en)
|
2003-09-19 |
2005-03-31 |
Barnes-Jewish Hospital |
Methods for screening osteogenic compounds targeting syk kinase and/or vav3 and uses of syk modulators and/or vav modulators
|
|
CN100475815C
(zh)
|
2003-09-25 |
2009-04-08 |
詹森药业有限公司 |
抑制hiv复制的嘌呤衍生物
|
|
KR100777885B1
(ko)
|
2003-10-03 |
2007-11-28 |
화이자 인코포레이티드 |
Ｈｉｖ 및 염증 치료를 위한 ｃｃｒ5 수용체 길항제 활성을갖는 이미다조피리딘 치환된 트로판 유도체
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
PE20051046A1
(es)
|
2003-11-28 |
2006-01-11 |
Novartis Ag |
Derivados de diaril-urea en el tratamiento de enfermedades dependientes de la quinasa de proteina
|
|
MY141255A
(en)
|
2003-12-11 |
2010-03-31 |
Memory Pharm Corp |
Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
|
|
WO2005063722A1
(en)
|
2003-12-19 |
2005-07-14 |
Rigel Pharmaceuticals, Inc. |
Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates
|
|
DK1704145T3
(da)
|
2004-01-12 |
2012-09-24 |
Ym Biosciences Australia Pty |
Selektive kinaseinhibitorer
|
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
|
CN1918158B
(zh)
|
2004-02-14 |
2011-03-02 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
|
US7745625B2
(en)
*
|
2004-03-15 |
2010-06-29 |
Bristol-Myers Squibb Company |
Prodrugs of piperazine and substituted piperidine antiviral agents
|
|
WO2005107760A1
(en)
|
2004-04-30 |
2005-11-17 |
Irm Llc |
Compounds and compositions as inducers of keratinocyte differentiation
|
|
US7754714B2
(en)
|
2004-05-18 |
2010-07-13 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
EP1598343A1
(de)
*
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
|
GB0419161D0
(en)
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
|
US20060047135A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Chadwick Scott T |
Process for preparing chloromethyl di-tert-butylphosphate
|
|
JP2008511659A
(ja)
|
2004-09-01 |
2008-04-17 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
２，４−ピリミジンジアミン化合物の合成
|
|
EP1794134A1
(de)
|
2004-09-29 |
2007-06-13 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 2-anilinopyrimidine als zellzyklus -kinase oder rezeptortyrosin-kinase inhibitoren, deren herstellung und verwendung als arzneimittel
|
|
ES2371924T3
(es)
|
2004-09-30 |
2012-01-11 |
Tibotec Pharmaceuticals |
Pirimidinas 5-carbo o heterociclo- sustituidas que inhiben el hiv.
|
|
CA2584808A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Rigel Pharmaceuticals, Inc. |
Substituted pyridines with activity on syk kinase
|
|
SI1814878T1
(sl)
|
2004-11-24 |
2012-06-29 |
Rigel Pharmaceuticals Inc |
Spojine spiro-2,4-pirimidindiamina in njihova uporaba
|
|
US7442716B2
(en)
|
2004-12-17 |
2008-10-28 |
Merck Frosst Canada Ltd. |
2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
|
|
ATE519759T1
(de)
|
2004-12-30 |
2011-08-15 |
Exelixis Inc |
Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren
|
|
AU2006206458B2
(en)
*
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
EP1883302A4
(en)
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
US20060251285A1
(en)
|
2005-05-05 |
2006-11-09 |
Mrs. Yen-Chen Chan |
[surge-proof damper]
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
BRPI0610876B8
(pt)
|
2005-06-08 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, formulação farmacêutica, e métodos de inibir uma atividade de uma jak cinase, e de inibir uma cascata de transdução de sinal em que jak3 cinase desempenha um papel
|
|
JP2008543855A
(ja)
|
2005-06-13 |
2008-12-04 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
変形性骨疾患を処置するための方法および組成物
|
|
EP1904479A2
(fr)
|
2005-07-11 |
2008-04-02 |
Sanofi-Aventis |
Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
ES2344275T3
(es)
|
2005-07-28 |
2010-08-23 |
Intervet International Bv |
Nuevos (tio) carbamatos de benzimidazol con actividad antiparasitaria y sintesis de ellos.
|
|
JP4981673B2
(ja)
|
2005-09-13 |
2012-07-25 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
安定性が改善されたクロロメチルフォスフェイト誘導体を含む組成物およびその製造方法
|
|
JP5191391B2
(ja)
*
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
US7713987B2
(en)
*
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
|
CA2634646C
(en)
|
2005-12-21 |
2012-04-10 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
TW200736232A
(en)
|
2006-01-26 |
2007-10-01 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
|
US7659280B2
(en)
*
|
2006-02-17 |
2010-02-09 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
|
|
ES2622493T3
(es)
*
|
2006-02-24 |
2017-07-06 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
|
US20090192158A1
(en)
|
2006-05-02 |
2009-07-30 |
Stacia Kargman |
Methods for Treating or Preventing Neoplasias
|
|
US7776855B2
(en)
|
2006-07-27 |
2010-08-17 |
Janssen Pharmaceutica N.V. |
Antimicrobial oxazolidinone prodrugs
|
|
JP5161233B2
(ja)
|
2006-10-19 |
2013-03-13 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
自己免疫疾患の処置のためのｊａｋキナーゼの阻害剤としての２，４−ピリミジンアミン誘導体
|
|
ATE540041T1
(de)
*
|
2006-11-21 |
2012-01-15 |
Rigel Pharmaceuticals Inc |
Prodrug-salze von 2,4-pyrimidindiaminverbindungen und anwendungen davon
|
|
CN101563327A
(zh)
|
2006-12-19 |
2009-10-21 |
健泰科生物技术公司 |
嘧啶类激酶抑制剂
|
|
PE20081636A1
(es)
|
2007-01-26 |
2009-01-10 |
Smithkline Beecham Corp |
Inhibidores de antranilamida para aurora quinasa
|
|
WO2008118822A1
(en)
|
2007-03-23 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US7834024B2
(en)
|
2007-03-26 |
2010-11-16 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
CN101903357A
(zh)
*
|
2007-07-17 |
2010-12-01 |
里格尔药品股份有限公司 |
作为pkc抑制剂的环状胺取代的嘧啶二胺
|